These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 21111526)

  • 41. The effect of growth hormone replacement therapy on adrenal androgen secretion in adult onset hypopituitarism.
    Isidori AM; Kaltsas GA; Perry L; Burrin JM; Besser GM; Monson JP
    Clin Endocrinol (Oxf); 2003 May; 58(5):601-11. PubMed ID: 12699442
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of acute physiological elevations of insulin on circulating androgen levels in nonobese women.
    Diamond MP; Grainger DA; Laudano AJ; Starick-Zych K; DeFronzo RA
    J Clin Endocrinol Metab; 1991 Apr; 72(4):883-7. PubMed ID: 1826009
    [TBL] [Abstract][Full Text] [Related]  

  • 43. GH-IGF-I axis in non-obese women with functional hyperandrogenism.
    Legan M; Kocijancic A; Prezelj J; Osredkar J; Fisker S
    J Endocrinol Invest; 2002 Sep; 25(8):691-5. PubMed ID: 12240900
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A study comparing the clinical and hormonal profile of late onset and persistent acne in adult females.
    Sardana K; Bansal P; Sharma LK; Garga UC; Vats G
    Int J Dermatol; 2020 Apr; 59(4):428-433. PubMed ID: 31898819
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.
    Kazerooni T; Dehghan-Kooshkghazi M
    Gynecol Endocrinol; 2003 Feb; 17(1):51-6. PubMed ID: 12724019
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recommendations for investigation of hyperandrogenism.
    Pugeat M; Déchaud H; Raverot V; Denuzière A; Cohen R; Boudou P;
    Ann Endocrinol (Paris); 2010 Feb; 71(1):2-7. PubMed ID: 20096825
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma testosterone, dehydroepiandrosterone sulfate, and cortisol in female patients with Huntington's disease.
    Markianos M; Panas M; Kalfakis N; Vassilopoulos D
    Neuro Endocrinol Lett; 2007 Apr; 28(2):199-203. PubMed ID: 17435662
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of atorvastatin on testosterone levels.
    Shawish MI; Bagheri B; Musini VM; Adams SP; Wright JM
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013211. PubMed ID: 33482034
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Establishing the cut off values of androgen markers in the assessment of polycystic ovarian syndrome.
    Nadaraja RND; Sthaneshwar P; Razali N
    Malays J Pathol; 2018 Apr; 40(1):33-39. PubMed ID: 29704382
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of carbamazepine and oxcarbazepine on the reproductive endocrine function in women with epilepsy.
    Löfgren E; Tapanainen JS; Koivunen R; Pakarinen A; Isojärvi JI
    Epilepsia; 2006 Sep; 47(9):1441-6. PubMed ID: 16981858
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diagnosis of hyperandrogenism: biochemical criteria.
    Stanczyk FZ
    Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):177-91. PubMed ID: 16772150
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dexamethasone suppressibility and adrenal and ovarian venous effluents of 5α-reduced C19 conjugates in hyperandrogenic women.
    Stanczyk FZ; Saxena T; Lobo RA
    J Steroid Biochem Mol Biol; 2014 Jan; 139():73-7. PubMed ID: 24121067
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum androgen levels in healthy premenopausal women with and without sexual dysfunction: Part A. Serum androgen levels in women aged 20-49 years with no complaints of sexual dysfunction.
    Guay A; Munarriz R; Jacobson J; Talakoub L; Traish A; Quirk F; Goldstein I; Spark R
    Int J Impot Res; 2004 Apr; 16(2):112-20. PubMed ID: 14999217
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Plasma C19 steroid sulphate levels and indices of androgen bioavailability in female pattern androgenic alopecia.
    Montalto J; Whorwood CB; Funder JW; Yong AB; Callan A; Davies HE; Connelly JF
    Clin Endocrinol (Oxf); 1990 Jan; 32(1):1-12. PubMed ID: 2139595
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relationship between serum dehydroepiandrosterone sulfate, androstenedione, and sex hormones in men and women.
    Phillips GB
    Eur J Endocrinol; 1996 Feb; 134(2):201-6. PubMed ID: 8630520
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hormone levels in middle-aged and elderly men with and without erectile dysfunction in Taiwan.
    Hwang TI; Juang GD; Yeh CH; Chang YH; Chou KY; Chen HE
    Int J Impot Res; 2006; 18(2):160-3. PubMed ID: 16121208
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High DHEAS/free testosterone ratio is related to better metabolic parameters in women with PCOS.
    Güdücü N; Kutay SS; Görmüş U; Kavak ZN; Dünder İ
    Gynecol Endocrinol; 2015 Jun; 31(6):495-500. PubMed ID: 25986306
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reference intervals for important serum sex steroid hormones, prostate-specific antigen, insulin-like growth factor-1 and IGF binding protein-3 concentration in a normal Kuwaiti adult male population.
    Kehinde EO; Akanji AO; Mojiminiyi OA; Al-Awadi KA; Al-Hunayan A; Bashir AA; Abraham MP
    Med Princ Pract; 2005; 14(5):342-8. PubMed ID: 16103701
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reference ranges for serum dehydroepiandrosterone sulfate and testosterone in adult men.
    Friedrich N; Völzke H; Rosskopf D; Steveling A; Krebs A; Nauck M; Wallaschofski H
    J Androl; 2008; 29(6):610-7. PubMed ID: 18599883
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Salivary testosterone may not serve as a screening test in the diagnosis of biochemical hyperandrogenism.
    Ambroziak U; Kuryłowicz A; Kępczyńska-Nyk A; Kondracka A; Gajda S; Sieńko D
    J Obstet Gynaecol Res; 2018 Jun; 44(6):1118-1125. PubMed ID: 29517119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.